Previous Close | 331.04 |
1-Year Change | -16.74% |
6-Months Change | 8.73% |
3-Months Change | 0.5% |
Moving Avg (50d) | 330.62 |
Moving Avg (200d) | 322.04 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 24.5B |
Beta (3-Years) | 1.04 |
Revenue Growth (ttm) | 0.6% |
Net Profit Margin (ttm) | 19.11% |
Return On Assets (ttm) | 14.9% |
EPS (ttm) | 7.42 |
PE Ratio (ttm) | 44.61 |
Dividend Yield | 0.23% |
Asset Description: | West Pharmaceutical Services, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-18 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
337.661 | 347.592 | 354.213 | 364.144 | 380.696 | 397.248 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.